Thus, the goal of this study was to examine the effect of ACE2 on VE-cadherin extracellular domain, and to analyze ACE2 and VE-cadherin in blood from COVID-19 patients with mild or severe disease in relation to disease activity score. This evidence concerns the gene ACE2 and COVID-19.